|
KLF9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.98199999535254E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.96700000310824E-08 |
| Normal-vs-Stage2 |
4.16749999954114E-07 |
| Normal-vs-Stage3 |
1.84299999705928E-08 |
| Normal-vs-Stage4 |
1.20220000621174E-09 |
| Stage1-vs-Stage2 |
9.684200E-01 |
| Stage1-vs-Stage3 |
1.666600E-01 |
| Stage1-vs-Stage4 |
3.555500E-03 |
| Stage2-vs-Stage3 |
3.309200E-01 |
| Stage2-vs-Stage4 |
4.387800E-02 |
| Stage3-vs-Stage4 |
3.407600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.9549999970906E-08 |
| Normal-vs-AfricanAmerican |
2.61660000333563E-08 |
| Normal-vs-Asian |
4.30440000309673E-08 |
| Caucasian-vs-AfricanAmerican |
3.026600E-01 |
| Caucasian-vs-Asian |
1.051200E-01 |
| AfricanAmerican-vs-Asian |
1.055370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.85940000460872E-08 |
| Normal-vs-Female |
1.65080000003037E-07 |
| Male-vs-Female |
4.554000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.84889999871518E-08 |
| Normal-vs-Extreme_Weight |
3.60130000265357E-08 |
| Normal-vs-Obese |
1.90369999764073E-08 |
| Normal-vs-Extreme_Obese |
8.3828000096986E-09 |
| Normal_Weight-vs-Extreme_Weight |
9.398800E-01 |
| Normal_Weight-vs-Obese |
1.483410E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.171000E-01 |
| Extreme_Weight-vs-Obese |
1.047950E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.078800E-01 |
| Obese-vs-Extreme_Obese |
1.978220E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.76800000195598E-08 |
| Normal-vs-Age(41-60Yrs) |
2.84730000021938E-07 |
| Normal-vs-Age(61-80Yrs) |
1.76759999970244E-08 |
| Normal-vs-Age(81-100Yrs) |
4.95099999997528E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.916000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.140800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.034960E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.656300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.527000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.576970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.97550000025082E-07 |
| Normal-VS-Type2 PRCC |
8.72880001612231E-09 |
| Normal-VS-KIRP CIMP |
8.88039997093415E-09 |
| Normal-VS-Unclassified PRCC |
7.14040000460159E-08 |
| Type1 PRCC-VS-Type2 PRCC |
8.876700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
7.322000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.802800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.960250E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.435800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.711500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.78519998783599E-09 |
| Normal-vs-N1 |
2.96009994293911E-10 |
| Normal-vs-N2 |
1.996080E-02 |
| N0-vs-N1 |
1.626410E-01 |
| N0-vs-N2 |
2.755600E-01 |
| N1-vs-N2 |
9.810300E-02 |
|
|
